Founded in 2018, APITBIO Co., Ltd. is a South Korean biotechnology company specializing in the development of innovative antibody-based therapeutics, particularly targeting cancer and infectious diseases. The company's mission is to address unmet medical needs by advancing novel biologics through comprehensive research and development processes, encompassing antibody screening, discovery, optimization, and production.

Antibody Therapeutics Development: APITBIO focuses on creating monoclonal and bispecific antibodies to target specific antigens associated with various diseases, aiming to enhance treatment efficacy and patient outcomes.

Private

Biotech